With energy prices easing and central banks signaling a slower pace of rate moves, investors are paying closer attention to companies that can stand on their own cash flow. When money is no longer free, cash generation and valuation discipline matter more. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that combine strong cash flow characteristics with discounted prices.
The stocks highlighted below are just a starting sample, since the full screen surfaced 59 more companies with equally compelling cash flow and valuation stories that are not covered in this article. To identify and analyze your own high-conviction ideas from this group, head straight into the Undervalued Stocks Based On Cash Flows screener.
Chugai Pharmaceutical (TSE:4519)
Overview: Chugai Pharmaceutical is a Japan based drug maker that focuses on high value biologic therapies for cancer, autoimmune and rare diseases, supported by research, development, manufacturing and global distribution, and benefits from its long standing relationship with Roche Holding AG.
Operations: Chugai Pharmaceutical generates essentially all of its ¥1,342,808 million revenue from pharmaceuticals sold in Japan and overseas.
Market Cap: ¥11,128.8 billion
Chugai Pharmaceutical stands out on this cash flow focused list because it combines a strong portfolio of oncology and specialty drugs with solid profitability, including a net profit margin of 35.1% and historically high Return on Equity near 23%. The stock is flagged as trading well below certain estimated fair value measures, suggesting the market may not fully reflect its pipeline or global reach. Recent news around AI driven drug discovery partnerships and progress on new indications such as MOGAD provide additional business context. At the same time, reliance on a few flagship drugs and its tight relationship with Roche create concentration and governance risks that investors need to weigh carefully.
Chugai Pharmaceutical’s rich cash flows and high margins could be masking an even bigger story in its valuation. Get the full picture with the DCF valuation analysis for Chugai Pharmaceutical
Build your own cash flow shortlist around ideas like Chugai Pharmaceutical
Chugai Pharmaceutical and the two other stocks in this article all came from a single screen, but the real value for you is in shaping a list around your own rules. Use our flexible Screener to mix filters like cash flows, valuation, balance sheet strength and risks, or jump straight into our curated Investing Ideas for ready made starting points.
JX Advanced Metals (TSE:5016)
Overview: JX Advanced Metals is a Japan based materials company that produces copper and rare metal products used in semiconductors, electronics and industrial applications, from high purity metals and powders to sputtering targets, shielding films and specialty chemicals.
Market Cap: ¥3,938.4 billion
JX Advanced Metals catches the eye because it links exposure to semiconductor and electronics demand with fundamentals such as a 22.9% Return on Equity and a net profit margin of 14.6%. Sales of ¥884.6 billion and net income of ¥104.6 billion for the year to March 2026 give investors real scale to work with. Earnings and revenue forecasts both point to continued growth. At the same time, the P/E of 26.7x is richer than many Metals and Mining peers and the share price has been highly volatile in recent months. A large buyback financed by convertible bonds adds another layer that investors should understand before deciding how comfortable they are with the risk and reward mix here.
JX Advanced Metals pairs semiconductor exposure with a 22.9% Return on Equity and rich margins, yet a 26.7x P/E and recent volatility raise questions. Get the full story in the 3 key rewards and 1 important major warning sign
Murata Manufacturing (TSE:6981)
Overview: Murata Manufacturing is a Japan based electronics company that supplies ceramic capacitors, sensors, batteries and wireless modules that sit inside smartphones, cars, data centers and industrial equipment worldwide. Its components support areas like communications, mobility, computing and energy, making Murata Manufacturing a key behind the scenes supplier to major hardware trends.
Operations: Murata Manufacturing generates most of its roughly ¥2.0t revenue from Components at about ¥1.25t and Devices and Modules at about ¥665b, with only a small amount from Others.
Market Cap: ¥13,508.4 billion
Murata Manufacturing earns attention on a cash flow screen because it links a broad footprint in capacitors, modules and automotive components with improving profitability, including a net margin of 13.8% and high quality earnings. Recent quarterly results and raised guidance for the year to March 2027 highlight stronger revenue, higher expected operating profit and support from yen weakness. New automotive grade components and expanded product data APIs show how it is positioning for electric vehicles and connected devices. At the same time, a 50.3x P/E, funding risk from external borrowing and very volatile trading remind you that execution needs to stay strong. The mix of forecast earnings growth, valuation signals and balance sheet questions makes this a stock worth a closer look.
Murata Manufacturing sits at the crossroads of high quality earnings, a 50.3x P/E and very volatile trading that could be masking a bigger story. Get the context in the analysis report for Murata Manufacturing
Seeking Alternatives Before The Crowd Moves
Fresh opportunities can move from quiet to breakout faster than most investors react. Use this momentum while it matters, before ideas stop flying under the radar. Consider acting while conditions are still favorable for early movers.
- Spot companies quietly building momentum in quality and value, then track them through the 18 high quality undervalued stocks before the crowd notices these fundamentals at current levels.
- Review the curated group of 20 cryptocurrency and blockchain stocks to follow developments in secure digital assets while sentiment is still shifting in and out of favor.
- Monitor potential infrastructure momentum by scanning 36 power grid technology and infrastructure stocks that could be positioned to benefit as grid upgrades move from plans to projects, instead of waiting until prices are already moving.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com